Taysha Gene Therapies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.About TSHA
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing.
CEOSean P. Nolan
CEOSean P. Nolan
Employees73
Employees73
HeadquartersDallas, Texas
HeadquartersDallas, Texas
Founded2019
Founded2019
Employees73
Employees73
TSHA Key Statistics
Market cap636.83M
Market cap636.83M
Price-Earnings ratio-6.81
Price-Earnings ratio-6.81
Dividend yield—
Dividend yield—
Average volume3.20M
Average volume3.20M
High today$2.51
High today$2.51
Low today$2.34
Low today$2.34
Open price$2.34
Open price$2.34
Volume2.76M
Volume2.76M
52 Week high$3.31
52 Week high$3.31
52 Week low$1.05
52 Week low$1.05
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TSHA. This list is generated using Robinhood data, and it’s not a recommendation.